Cargando…
Platelets Increase the Expression of PD-L1 in Ovarian Cancer
SIMPLE SUMMARY: One-third of patients with ovarian cancer have elevated platelet counts associated with a poor prognosis. We found that platelets increase the expression of immune checkpoint (PD-L1) in ovarian cancer in mice and patients. Reducing platelet counts or inhibiting platelet function redu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139585/ https://www.ncbi.nlm.nih.gov/pubmed/35626102 http://dx.doi.org/10.3390/cancers14102498 |
_version_ | 1784714893499301888 |
---|---|
author | Cho, Min Soon Lee, Hani Gonzalez-Delgado, Ricardo Li, Dan Sasano, Tomoyuki Carlos-Alcalde, Wendolyn Ma, Qing Liu, Jinsong Sood, Anil K. Afshar-Kharghan, Vahid |
author_facet | Cho, Min Soon Lee, Hani Gonzalez-Delgado, Ricardo Li, Dan Sasano, Tomoyuki Carlos-Alcalde, Wendolyn Ma, Qing Liu, Jinsong Sood, Anil K. Afshar-Kharghan, Vahid |
author_sort | Cho, Min Soon |
collection | PubMed |
description | SIMPLE SUMMARY: One-third of patients with ovarian cancer have elevated platelet counts associated with a poor prognosis. We found that platelets increase the expression of immune checkpoint (PD-L1) in ovarian cancer in mice and patients. Reducing platelet counts or inhibiting platelet function reduced the expression of PD-L1 in tumors. We investigated the mechanism of platelet-induced PD-L1 and showed that platelets increase PD-L1 on cancer cells both directly (contact-dependent through NF-κB signaling) and indirectly (contact-independent via TFGβ released from platelets through TFGβR1/Smad signaling). Our results show that platelets dampen the antitumor immune response in the tumor microenvironment. Based on our preclinical results, we speculate that platelet counts might be a predictive biomarker for immunotherapy, i.e., patients with thrombocytosis respond better to anti-PD1/PDL-1 therapy. On the other hand, the use of aspirin or other antiplatelet reagents may impact the effectiveness of immunotherapy. These speculations need to be examined in clinical trials. ABSTRACT: The interactions between platelets and cancer cells activate platelets and enhance tumor growth. Platelets increase proliferation and epithelial–mesenchymal transition in cancer cells, inhibit anoikis, enhance the extravasation of cancer cells, and protect circulating tumor cells against natural killer cells. Here, we have identified another mechanism by which platelets dampen the immune attack on cancer cells. We found that platelets can blunt the antitumor immune response by increasing the expression of inhibitory immune checkpoint (PD-L1) on ovarian cancer cells in vitro and in vivo. Platelets increased PD-L1 in cancer cells via contact-dependent (through NF-κB signaling) and contact-independent (through TFGβR1/Smad signaling) pathways. Inhibition of NF-κB or TGFβR1 signaling in ovarian cancer cells abrogated platelet-induced PD-L1 expression. Reducing platelet counts or inhibiting platelet functions reduced the expression of PD-L1 in ovarian cancer. On the other hand, an increase in platelet counts increased the expression of PD-L1 in tumor-bearing mice. |
format | Online Article Text |
id | pubmed-9139585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91395852022-05-28 Platelets Increase the Expression of PD-L1 in Ovarian Cancer Cho, Min Soon Lee, Hani Gonzalez-Delgado, Ricardo Li, Dan Sasano, Tomoyuki Carlos-Alcalde, Wendolyn Ma, Qing Liu, Jinsong Sood, Anil K. Afshar-Kharghan, Vahid Cancers (Basel) Article SIMPLE SUMMARY: One-third of patients with ovarian cancer have elevated platelet counts associated with a poor prognosis. We found that platelets increase the expression of immune checkpoint (PD-L1) in ovarian cancer in mice and patients. Reducing platelet counts or inhibiting platelet function reduced the expression of PD-L1 in tumors. We investigated the mechanism of platelet-induced PD-L1 and showed that platelets increase PD-L1 on cancer cells both directly (contact-dependent through NF-κB signaling) and indirectly (contact-independent via TFGβ released from platelets through TFGβR1/Smad signaling). Our results show that platelets dampen the antitumor immune response in the tumor microenvironment. Based on our preclinical results, we speculate that platelet counts might be a predictive biomarker for immunotherapy, i.e., patients with thrombocytosis respond better to anti-PD1/PDL-1 therapy. On the other hand, the use of aspirin or other antiplatelet reagents may impact the effectiveness of immunotherapy. These speculations need to be examined in clinical trials. ABSTRACT: The interactions between platelets and cancer cells activate platelets and enhance tumor growth. Platelets increase proliferation and epithelial–mesenchymal transition in cancer cells, inhibit anoikis, enhance the extravasation of cancer cells, and protect circulating tumor cells against natural killer cells. Here, we have identified another mechanism by which platelets dampen the immune attack on cancer cells. We found that platelets can blunt the antitumor immune response by increasing the expression of inhibitory immune checkpoint (PD-L1) on ovarian cancer cells in vitro and in vivo. Platelets increased PD-L1 in cancer cells via contact-dependent (through NF-κB signaling) and contact-independent (through TFGβR1/Smad signaling) pathways. Inhibition of NF-κB or TGFβR1 signaling in ovarian cancer cells abrogated platelet-induced PD-L1 expression. Reducing platelet counts or inhibiting platelet functions reduced the expression of PD-L1 in ovarian cancer. On the other hand, an increase in platelet counts increased the expression of PD-L1 in tumor-bearing mice. MDPI 2022-05-19 /pmc/articles/PMC9139585/ /pubmed/35626102 http://dx.doi.org/10.3390/cancers14102498 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cho, Min Soon Lee, Hani Gonzalez-Delgado, Ricardo Li, Dan Sasano, Tomoyuki Carlos-Alcalde, Wendolyn Ma, Qing Liu, Jinsong Sood, Anil K. Afshar-Kharghan, Vahid Platelets Increase the Expression of PD-L1 in Ovarian Cancer |
title | Platelets Increase the Expression of PD-L1 in Ovarian Cancer |
title_full | Platelets Increase the Expression of PD-L1 in Ovarian Cancer |
title_fullStr | Platelets Increase the Expression of PD-L1 in Ovarian Cancer |
title_full_unstemmed | Platelets Increase the Expression of PD-L1 in Ovarian Cancer |
title_short | Platelets Increase the Expression of PD-L1 in Ovarian Cancer |
title_sort | platelets increase the expression of pd-l1 in ovarian cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139585/ https://www.ncbi.nlm.nih.gov/pubmed/35626102 http://dx.doi.org/10.3390/cancers14102498 |
work_keys_str_mv | AT chominsoon plateletsincreasetheexpressionofpdl1inovariancancer AT leehani plateletsincreasetheexpressionofpdl1inovariancancer AT gonzalezdelgadoricardo plateletsincreasetheexpressionofpdl1inovariancancer AT lidan plateletsincreasetheexpressionofpdl1inovariancancer AT sasanotomoyuki plateletsincreasetheexpressionofpdl1inovariancancer AT carlosalcaldewendolyn plateletsincreasetheexpressionofpdl1inovariancancer AT maqing plateletsincreasetheexpressionofpdl1inovariancancer AT liujinsong plateletsincreasetheexpressionofpdl1inovariancancer AT soodanilk plateletsincreasetheexpressionofpdl1inovariancancer AT afsharkharghanvahid plateletsincreasetheexpressionofpdl1inovariancancer |